Home/BioLab Holdings/Jaime Leija
JL

Jaime Leija

Co-Founder

BioLab Holdings

Therapeutic Areas

BioLab Holdings Pipeline

DrugIndicationPhase
Microlyte® SAM™ Commercial LaunchChronic Wounds (e.g., Diabetic Foot Ulcers, Venous Leg Ulcers)Commercial
Amniotic Membrane Allograft PortfolioChronic and Hard-to-Heal WoundsCommercial